Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Class A common stock | Options Exercise | $245K | +429K | +99.64% | $0.57* | 860K | Apr 26, 2023 | Direct | |
transaction | VAXX | Class A common stock | Options Exercise | $56.3K | +46.5K | +5.41% | $1.21 | 906K | Apr 26, 2023 | Direct | |
holding | VAXX | Class A common stock | 13.8K | Apr 26, 2023 | Held by spouse | F1 | |||||
holding | VAXX | Class B common stock | 1.1M | Apr 26, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Stock option (right to buy) | Options Exercise | $0 | -429K | -81.25% | $0.00 | 99K | Apr 26, 2023 | Class A common stock | 429K | $0.57 | Direct | F2 |
transaction | VAXX | Stock option (right to buy) | Options Exercise | $0 | -46.5K | -5.97% | $0.00 | 733K | Apr 26, 2023 | Class A common stock | 46.5K | $1.21 | Direct | F3 |
Id | Content |
---|---|
F1 | These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest. |
F2 | These options are subject to a four-year vesting schedule, with 25% having vested on December 30, 2020 and the remainder vesting in thirty-six equal installments each month during the remainder of the vesting period |
F3 | These options are subject to a four-year vesting schedule, beginning on June 2, 2020, vesting in equal installments each month during the vesting period. |